Inflammatory biomarkers (Il-6 and TNFα) and an endothelial dysfunction biomarker (ET-1) showed significantly higher levels in T2DM-CKD, and a positive correlation with TMAO in the T2DM-CKD patients. The gene discussed is TNF; the disease is type 2 diabetes mellitus.